Clinical Trial Update: Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In Adults [Phase 2]

View source ↗

Summary

Phase 2 trial assessing effects of EPA- versus DHA-rich fish oils on lipoprotein metabolism in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lipoprotein Metabolism Disorders
• Pcsk9-related Lipid Abnormalities

Drugs mentioned

• DHA-rich fish oil (docosahexaenoic acid)
• EPA-rich fish oil (eicosapentaenoic acid)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lipoprotein Metabolism, PCSK9 | Phase 2 | Status: COMPLETED | Results posted: 2020-12-03